US HB167 | 2023-2024 | 118th Congress
Status
Spectrum: Moderate Partisan Bill (Republican 10-3)
Status: Introduced on January 9 2023 - 25% progression, died in committee
Action: 2023-01-20 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 9 2023 - 25% progression, died in committee
Action: 2023-01-20 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain urgent-use compounded medications, and for other purposes.
Title
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
Sponsors
Rep. Morgan Griffith [R-VA] | Rep. Henry Cuellar [D-TX] | Rep. Jeff Duncan [R-SC] | Rep. Diana Harshbarger [R-TN] |
Rep. Gary Palmer [R-AL] | Rep. Earl Carter [R-GA] | Rep. Neal Dunn [R-FL] | Rep. Debbie Lesko [R-AZ] |
Rep. Mariannette Miller-Meeks [R-IA] | Rep. John Moolenaar [R-MI] | Rep. Mark Pocan [D-WI] | Rep. Wiley Nickel [D-NC] |
Rep. Ben Cline [R-VA] |
History
Date | Chamber | Action |
---|---|---|
2023-01-20 | House | Referred to the Subcommittee on Health. |
2023-01-09 | House | Referred to the House Committee on Energy and Commerce. |
2023-01-09 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/167/all-info |
Text | https://www.congress.gov/118/bills/hr167/BILLS-118hr167ih.pdf |